135 results
8-K
EX-99.1
MXL
MaxLinear Inc
24 Apr 24
MaxLinear, Inc. Announces First Quarter 2024 Financial Results
4:06pm
delays and consolidation trends in our industry; inability to make substantial research and development investments; delays or expenses caused … in shares of common stock in February 2024; (iv) amortization of purchased intangible assets; (v) research and development funded by others; (vi
8-K
EX-99.1
MXL
MaxLinear Inc
31 Jan 24
MaxLinear, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
4:05pm
; and accretion of discount on contingent consideration to interest expense.
Research and development funded by others represents proceeds received under …
Net revenue
Cost of net revenue
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Impairment losses
8-K
EX-99.1
yfnssg
25 Oct 23
MaxLinear, Inc. Announces Third Quarter 2023 Financial Results
4:07pm
8-K
EX-99.1
s70glap3ihu upcp6mdd
26 Jul 23
MaxLinear, Inc. Announces Second Quarter 2023 Financial Results
4:20pm
8-K
EX-99.1
ki5er5hg3xnikg
9 May 23
MaxLinear Investor Presentation May 2023
4:32pm
8-K
EX-99.1
kwosjt
26 Apr 23
MaxLinear, Inc. Announces First Quarter 2023 Financial Results
4:08pm
8-K
EX-99.1
n6duepxy w7g120a05wc
25 Oct 22
MaxLinear, Inc. Announces Third Quarter 2022 Financial Results
4:06pm
425
EX-99.1
ogrms5ni7dr7
27 Jul 22
Business combination disclosure
8:35pm
8-K
EX-99.1
2gop7n
27 Jul 22
MaxLinear, Inc. Announces Second Quarter 2022 Financial Results
4:08pm
424B3
6fp96 hw59t9t3i7wer7
13 Jul 22
Prospectus supplement
4:45pm